Build status - In Progress

CART-38 in Adult AML and MM Patients - 1

Investigational Treatment for Adult Acute Myeloid Leukemia and Multiple Myeloma

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

See protocol section 2 See protocol section 2 See protocol section 4

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

This study investigates a treatment for adults with acute myeloid leukemia (AML) and multiple myeloma (MM).

The purpose of this study is to evaluate the effects of an investigational treatment on these conditions.

  • Who can participate: Adults aged 18 and older diagnosed with acute myeloid leukemia or multiple myeloma may be eligible. Additional criteria will be provided by the study coordinators.
  • Study details: Participants will be monitored to assess the effects on AML and MM.
Updated on 27 Jun 2025. Study ID: 689878443
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research